Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the ...

Feb 10 () - Quest Diagnostics on Tuesday forecast 2026 profit and revenue above Wall Street ​estimates after beating ...

Analysts estimate that Quest Diagnostics will report an earnings per share (EPS) of $2.35. Anticipation surrounds Quest ...

Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. | Quest ...

Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...

Quest Diagnostics (DGX) stock hits a 52-week high as the company beats estimates with its Q4 2025 financials and set its 2026 ...

The Quest Diagnostics patient service center at 1 Randall Square reopened last week following renovations. Quest leaders ...

Quest Diagnostics on Monday said it completed its previously announced acquisition of its joint venture partners’ interests in Mid America Clinical Laboratories. Under the all-cash equity deal, ...

Quest Diagnostics Incorporated DGX on Tuesday reported fourth-quarter adjusted earnings of $2.42 per share, beating the consensus of $2.36. The provider of diagnostic information services reported ...

Quest Diagnostics completed its acquisition of select assets from Fresenius Medical Care’s laboratory business. As part of the transaction, the Secaucus-based testing provider will now offer ...

Quest Diagnostics Incorporated (NYSE:DGX) Q4 2025 Earnings Call Transcript February 10, 2026 Quest Diagnostics Incorporated misses on earnings expectations. Reported EPS is $2.19 EPS, expectations ...